Value in Oncology

In an effort to contain healthcare costs and to improve the quality of cancer care via shared decision-making, the ASCO Value in Cancer Care Task Force developed a conceptual framework to assess the value of new cancer drugs versus current standard-of-care treatments in 2 clinical settings: advanced disease and potentially curative disease. Read More ›

Communication Gap with Oncologists, Not Cost, Tops Patients’ Value Priorities

By Chase Doyle

Value in Oncology

The definition of value by patients with cancer does not necessarily coincide with other definitions by other stakeholders. According to one breast cancer advocate, when patients are asked to define “value” in the context of their cancer treatment, cost is not the first thing that comes to mind. Read More ›

Value in Oncology

December 2021, Vol 9, No 1

Subscribe to
Rheumatology Practice Management

I'd like to receive:

Value in Oncology

December 2021, Vol 9, No 1

Subscribe to Rheumatology Practice Management

I'd like to receive:

Subscribe to
Rheumatology Practice Management